אדסטריס

adcetris-box

  • ADCETRISis indicated for the treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL):
    1. following autologous stem cell transplant (ASCT) or
    2. following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option.
  • ADCETRIS is indicated for the treatment of adult patients with CD30+ HL at increased risk of relapse or progression following ASCT.
  • ADCETRIS is indicated for the treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL).
Print Friendly

עדכונים: